Stocks and Investing Stocks and Investing
Tue, May 7, 2024
Mon, May 6, 2024

Kevin Steinke Maintained (CCRN) at Buy with Decreased Target to $21 on, May 6th, 2024


Published on 2024-10-28 11:02:12 - WOPRAI, Kevin Steinke
  Print publication without navigation


Kevin Steinke of Barrington Research, Maintained "Cross Country Healthcare, Inc." (CCRN) at Buy with Decreased Target from $24 to $21 on, May 6th, 2024.

Kevin has made no other calls on CCRN in the last 4 months.



There are 2 other peers that have a rating on CCRN. Out of the 2 peers that are also analyzing CCRN, 1 agrees with Kevin's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tobey Sommer of "Truist Securities" Maintained at Hold with Decreased Target to $16 on, Thursday, February 22nd, 2024


This is the rating of the analyst that currently disagrees with Kevin


  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $19 on, Thursday, May 2nd, 2024
Contributing Sources